Guy Braunstein
Chief Tech/Sci/R&D Officer at IDORSIA LTD
Net worth: 494 176 $ as of 2024-02-28
Profile
Presently, Guy Braunstein is Chief Medical Officer & Executive Vice President at Idorsia Ltd.
Dr. Braunstein is also on the board of Actelion Clinical Research, Inc.
In the past he was Medical Director at Fisons Pharmaceuticals, Chief Medical Officer for Serono International SA, Director-Europe Development & Medical Affairs at Chiron Corp., Executive VP & Head-Global Clinical Development at Actelion Ltd.
and Chief Medical Officer of Merck Serono SA.
Guy Braunstein received a doctorate from Université Paris 1 Panthéon-Sorbonne.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
IDORSIA LTD.
0.10% | 2022-12-30 | 194,958 ( 0.10% ) | 494 176 $ | 2024-02-28 |
Guy Braunstein active positions
Companies | Position | Start |
---|---|---|
IDORSIA LTD | Chief Tech/Sci/R&D Officer | 2017-03-02 |
Actelion Clinical Research, Inc. | Director/Board Member | - |
Former positions of Guy Braunstein
Companies | Position | End |
---|---|---|
ACTELION | Corporate Officer/Principal | 2016-12-31 |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Corporate Officer/Principal | 2008-12-31 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 2002-12-31 |
Fisons Pharmaceuticals | Corporate Officer/Principal | 1995-12-31 |
Serono International SA | Corporate Officer/Principal | - |
Training of Guy Braunstein
Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
IDORSIA LTD | Health Technology |
Private companies | 6 |
---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Health Technology |
Fisons Pharmaceuticals | |
Serono International SA | |
Actelion Clinical Research, Inc. |